MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
May 18, 2020

FDA Grants Fast Track Designation for Heart Failure Developmental Treatment

By Adam Hochron
The FDA has granted fast track designation for omecamtiv mecarbil for the treatment of chronic heart failure with reduced ejection fraction...
FDA Grants Fast Track Designation for Heart Failure Developmental Treatment
May 18, 2020

Masitinib Reduced Exacerbation Rate in Patients with Severe Persistent Asthma

By Jeff Craven /alert Contributor
The selective tyrosine kinase inhibitor masitinib was effective as an add-on therapy in reducing exacerbations in patients with severe persistent asthma uncontrolled by oral corticosteroids...
Masitinib Reduced Exacerbation Rate in Patients with Severe Persistent Asthma
May 15, 2020

Patient Characteristics May Not Always Determine Effectiveness of Biologics for Asthma

By Jeff Craven /alert Contributor
Patient characteristics alone may not determine who is a good candidate for biologics for treatment of asthma, according to a recent case study...
Patient Characteristics May Not Always Determine Effectiveness of Biologics for Asthma
May 13, 2020

Positive Results Reported from Phase 3 Plaque Psoriasis Trial

By Adam Hochron

A phase 3 clinical trial for apremilast showed “significant improvements” in patients with mild-to-moderate plaque psoriasis, according to a press release from the manufacturer...

Positive Results Reported from Phase 3 Plaque Psoriasis Trial
May 11, 2020

First-Line Andecaliximab with mFOLFOX6 Fails to Improve Advanced Gastric Cancer Survival

By Michael Vlessides, /alert Contributor
An international, multi-center investigation has concluded that combining the experimental humanized monoclonal antibody andecaliximab with modified FOLFOX6 therapy does not improve overall survival...
First-Line Andecaliximab with mFOLFOX6 Fails to Improve Advanced Gastric Cancer Survival
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

REFILE-POC test for chlamydia, gonorrhea as good as lab-based assays

(Fixes typo in para 3 of May 19 story.) By Anne Harding NEW YORK (Reuters Health) - A new 30-minute point-of-care (POC) test using self-collected vaginal swabs works as well as lab-based molecular Read More »

REFILE-Elevated fecal calprotectin points to intestinal inflammation in COVID-19 patients

(Fixes typo in para 10 of story posted May 19) By Scott Baltic NEW YORK (Reuters Health) - New data showing elevated fecal calprotectin (FC) levels in COVID-19 patients add to mounting evidence that Read More »

Visual and auditory training improve different aspects of schizophrenia

By Marilynn Larkin NEW YORK (Reuters Health) - Visual training and auditory training were "differentially efficient" at improving cognitive deficits and symptoms in a randomized trial of schizophrenia Read More »

New genetic tool could one day diagnose rheumatic disease faster than a clinician

By Marilynn Larkin NEW YORK (Reuters Health) - A novel diagnostic tool that combines a patient's own genetic data with genetic risk scores zeroed in on the most probable diagnosis among five different Read More »

UPDATE 1-Does drug touted by Trump work on COVID-19? After data debacle, we still don't know

(Adds retraction of Lancet article, repeats story to additional clients) By Kate Kelland and Alistair Smout LONDON (Reuters) - Scientists are resuming COVID-19 trials of the now world-famous drug Read More »

Protesters should 'highly consider' coronavirus tests, U.S. health official says

By Michael Erman NEW YORK (Reuters) - A top U.S. health official cautioned on Thursday that protests sweeping across the country could increase the spread of the novel coronavirus, particularly in Read More »

Advanced melanoma more prevalent among unmarried patients

By Lisa Rapaport (Reuters Health) - Single adults are more likely to be diagnosed with advanced melanoma and have shorter overall survival than their married counterparts, a recent study suggests. Read More »

Extensive financial ties between industry and U.S. medical society leaders

By Lisa Rappaport (Reuters Health) - Almost three quarters of leaders of U.S. professional medical associations have financial ties to industry, a new study suggests. Researchers examined 2017-2019 Read More »

See all news »

Featured Video

Major Advances in Urology Care

Major Advances in Urology Care

Guy T. Bernstein, MD, FACS, of Urology Health Specialists discusses major advances in care over the next five years. 

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information